- Home
- ARCO vs CERT Comparison
ARCO vs CERT Comparison
Compare ARCO & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCO
- CERT
- Stock Information
- Founded
- ARCO 2007
- CERT 2008
- Country
- ARCO Uruguay
- CERT United States
- Employees
- ARCO N/A
- CERT N/A
- Industry
- ARCO Restaurants
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- ARCO Consumer Discretionary
- CERT Technology
- Exchange
- ARCO Nasdaq
- CERT Nasdaq
- Market Cap
- ARCO 1.8B
- CERT 1.9B
- IPO Year
- ARCO 2011
- CERT 2020
- Fundamental
- Price
- ARCO $7.29
- CERT $12.61
- Analyst Decision
- ARCO Buy
- CERT Buy
- Analyst Count
- ARCO 1
- CERT 7
- Target Price
- ARCO $12.00
- CERT $15.92
- AVG Volume (30 Days)
- ARCO 1.2M
- CERT 1.0M
- Earning Date
- ARCO 03-12-2025
- CERT 02-27-2025
- Dividend Yield
- ARCO 3.29%
- CERT N/A
- EPS Growth
- ARCO N/A
- CERT N/A
- EPS
- ARCO 0.69
- CERT N/A
- Revenue
- ARCO $4,501,397,000.00
- CERT $372,797,000.00
- Revenue This Year
- ARCO $5.31
- CERT $10.20
- Revenue Next Year
- ARCO $7.85
- CERT $10.01
- P/E Ratio
- ARCO $10.36
- CERT N/A
- Revenue Growth
- ARCO 7.82
- CERT 5.62
- 52 Week Low
- ARCO $7.02
- CERT $9.41
- 52 Week High
- ARCO $13.20
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- ARCO 39.69
- CERT 66.73
- Support Level
- ARCO $7.14
- CERT $10.46
- Resistance Level
- ARCO $7.60
- CERT $12.21
- Average True Range (ATR)
- ARCO 0.21
- CERT 0.60
- MACD
- ARCO 0.02
- CERT 0.15
- Stochastic Oscillator
- ARCO 38.28
- CERT 97.47
About ARCO Arcos Dorados Holdings Inc. Shares
Arcos Dorados Holdings Inc operates McDonald's-branded restaurants in approximately 20 countries and territories in Latin America and the Caribbean. It functions through two sources which include company-operated restaurants and franchised restaurants segment. Their menu includes hamburgers, McNuggets, salad, sandwiches, french fries and others.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.